Desogestrel (DSG) is a third-generation 19-nortestosterone derivative progestogen. It is contained in many oral contraceptive preparations, both combined (COCs) to ethinyl-estradiol (EE) or alone in a progestin-only pill (POP). Its principal metabolite (etonogestrel, ETN) is the only progestin used for intravaginal combined contraception and one of the most used for subdermal hormonal contraception.
Pharmacokinetic evaluation of desogestrel as a female contraceptive / Grandi, Giovanni; Cagnacci, Angelo; Volpe, Annibale. - In: EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. - ISSN 1742-5255. - STAMPA. - 10:1(2014), pp. 1-10. [10.1517/17425255.2013.844229]
Pharmacokinetic evaluation of desogestrel as a female contraceptive
GRANDI, GIOVANNI;CAGNACCI, Angelo;VOLPE, Annibale
2014
Abstract
Desogestrel (DSG) is a third-generation 19-nortestosterone derivative progestogen. It is contained in many oral contraceptive preparations, both combined (COCs) to ethinyl-estradiol (EE) or alone in a progestin-only pill (POP). Its principal metabolite (etonogestrel, ETN) is the only progestin used for intravaginal combined contraception and one of the most used for subdermal hormonal contraception.File | Dimensione | Formato | |
---|---|---|---|
expert opinion 2014.pdf
Accesso riservato
Descrizione: pdf of the article
Tipologia:
Versione pubblicata dall'editore
Dimensione
393.63 kB
Formato
Adobe PDF
|
393.63 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris